| Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy … P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ... The Lancet 392 (10151), 940-949, 2018 | 690 | 2018 |
| Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary … SD Wiviott, E Braunwald, CH McCabe, I Horvath, M Keltai, JPR Herrman, ... The Lancet 371 (9621), 1353-1363, 2008 | 615 | 2008 |
| Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the … DJFM Thuijs, AP Kappetein, PW Serruys, FW Mohr, MC Morice, MJ Mack, ... The Lancet 394 (10206), 1325-1334, 2019 | 533 | 2019 |
| Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity IG Horvath, A Nemeth, Z Lenkey, N Alessandri, F Tufano, P Kis, ... Journal of hypertension 28 (10), 2068-2075, 2010 | 478 | 2010 |
| Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis D Aradi, A Komócsi, A Vorobcsuk, O Rideg, M Tőkés-Füzesi, T Magyarlaki, ... American heart journal 160 (3), 543-551, 2010 | 266 | 2010 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 248 | 2019 |
| Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction: systematic overview and meta-analysis A Vorobcsuk, A Kónyi, D Aradi, IG Horváth, I Ungi, Y Louvard, A Komócsi American heart journal 158 (5), 814-821, 2009 | 228 | 2009 |
| Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial J Bartunek, A Terzic, BA Davison, GS Filippatos, S Radovanovic, ... European heart journal 38 (9), 648-660, 2017 | 225 | 2017 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 190 | 2019 |
| Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing: Impact of Prasugrel and High-Dose … D Aradi, A Tornyos, T Pintér, A Vorobcsuk, A Kónyi, J Faluközy, G Veress, ... Journal of the American College of Cardiology 63 (11), 1061-1070, 2014 | 131 | 2014 |
| Apelin increases cardiac contractility via protein kinase Cε-and extracellular signal-regulated kinase-dependent mechanisms A Perjes, R Skoumal, O Tenhunen, A Konyi, M Simon, IG Horváth, ... PloS one 9 (4), e93473, 2014 | 109 | 2014 |
| Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Results of the … D Dudek, W Mielecki, F Burzotta, M Gasior, A Witkowski, IG Horvath, ... American heart journal 160 (5), 966-972, 2010 | 109 | 2010 |
| Comparison of aortic and carotid arterial stiffness parameters in patients with verified coronary artery disease B Gaszner, Z Lenkey, M Illyés, Z Sárszegi, IG Horváth, B Magyari, ... Clinical cardiology 35 (1), 26-31, 2012 | 61 | 2012 |
| Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility I Szokodi, R Kerkelä, AM Kubin, B Sármán, S Pikkarainen, A Kónyi, ... Circulation 118 (16), 1651-1658, 2008 | 58 | 2008 |
| AIM2-driven inflammasome activation in heart failure Z Onódi, M Ruppert, D Kucsera, AA Sayour, VE Tóth, G Koncsos, J Novák, ... Cardiovascular research 117 (13), 2639-2651, 2021 | 53 | 2021 |
| Justification of 150 mg clopidogrel in patients with high on‐clopidogrel platelet reactivity D Aradi, O Rideg, A Vorobcsuk, T Magyarlaki, B Magyari, A Kónyi, T Pintér, ... European journal of clinical investigation 42 (4), 384-392, 2012 | 52 | 2012 |
| Effects of magnesium supplementation on the glutathione redox system in atopic asthmatic children O Bede, D Nagy, A Suranyi, I Horvath, M Szlávik, K Gyurkovits Inflammation Research 57, 279-286, 2008 | 47 | 2008 |
| Overview of large animal myocardial infarction models E Lukács, B Magyari, L Tóth, Z Petrási, I Repa, A Koller, I Horváth Acta physiologica Hungarica 99 (4), 365-381, 2012 | 46 | 2012 |
| Hemorheological and hemodynamical parameters in patients with ischemic heart disease at rest and at peak exercise K Toth, T Habon, I Horvath, B Mezey, I Juricskay, GY Mozsik Clinical Hemorheology and Microcirculation 14 (3), 329-338, 1994 | 43 | 1994 |
| Effect of pre-hospital ticagrelor during the first 24 h after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: the … G Montalescot, AW van’t Hof, L Bolognese, WJ Cantor, A Cequier, ... JACC: Cardiovascular Interventions 9 (7), 646-656, 2016 | 38 | 2016 |
